共 230 条
[1]
Chiesa F(1999)Surfing prognostic factors in head and neck cancer at the millennium Oral Oncol 35 590-596
[2]
Mauri S(1991)Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry J Nucl Med Off Publ Soc Nucl Med. 32 1548-1555
[3]
Tradati N(1995)In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and J Nucl Med Off Publ Soc Nucl Med. 36 252-258
[4]
Calabrese L(2003)-methionine in squamous-cell carcinoma of the head and neck N Engl J Med 349 2091-2098
[5]
Giugliano G(2010)Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer Lancet Oncol. 11 21-28
[6]
Ansarin M(2009)Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival Radiother Oncol J Eur Soc Ther Radiol Oncol. 92 4-14
[7]
Haberkorn U(2006)MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients J Clin Oncol Off J Am Soc Clin Oncol. 24 2873-2878
[8]
Strauss LG(2012)Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial Int J Radiat Oncol Biol Phys 82 548-553
[9]
Reisser C(2014)Analysis of pretreatment FDG PET SUV parameters in head-and-neck cancer: tumor SUV mean has superior prognostic value Oral Oncol 50 802-808
[10]
Haag D(2014)The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [(18)F] fluorodeoxyglucose positron emission tomography scan PLoS One 9 e96999-1389